The objectives of the study were to investigate the feasibility of the modified nephelometry technique to measure immunoglobulin G and A in seminal fluid and to evaluate their use in diagnosis and follow-up of chronic prostatitis.
Introduction
The introduction of the NIH classification for prostatitis in 1999 1 has defined clinical and research aspects of chronic prostatitis and is now internationally regarded as the basis for research. However, the search for more specific diagnostic tools and more efficient treatment methods remains.
We therefore found it valuable to publish the results of a project we conducted in the mid 1990s on this new background.
The significance of immunoparameters in postatic exprimate (EPS) and seminal fluid in patients with chronic prostatitis was shown by Shortliffe et al 2 -4 using radioimmunoassay (RIA). They found significantly raised values in patients with chronic prostatitis and normalization along with improving symptoms. The clinical use of this information is limited by difficulties to obtain EPS and the cost and availability of the RIA.
Using a similar approach to Weidner when modifying the four-glass test, 5 we chose to investigate the use of nephelometry to detect immunoparameters in easily obtainable seminal fluid. Nephelometry is a commonly available laboratory technique to obtain a measurement of the amount of immunoglobulins accurately and rapidly. By measuring the side-scattered light, nephelometry quantifies the movement of particles in a solution (turbidity) caused by the interaction of immunoglobulins and anti-immunoglobulin that has been added.
We focused on IgG and IgA as previous studies 4,11 using RIA had shown significant changes in these in patients with chronic prostatitis. Our target was to investigate the feasibility of this technique and to compare the results with literature values for healthy individuals and chronic prostatitis patients and to monitor their behaviour during the healing process.
Patients and methods

Population
Between 1993 and 1995, 34 consecutive patients with chronic prostatitis (group 'CP') taking part in a trial of transrectal hyperthermia with antibiotic cover for chronic abacterial/bacterial prostatitis (NIH II/IIIa) at the Urology Department of the RWTH Aachen University Clinics were included in this study. Their age ranged from 24 to 64 y with a median age of 45 y. Each patient complained of prostatitis symptoms for more than 6 months and had received at least two unsuccessful treatments in the past. By using the EPS or the VB3 of the four-glass-test 17 patients were diagnosed with chronic abacterial prostatitis (NIH IIIa; group 'CAP'). A further 17 patients were assigned to the group with chronic bacterial prostatitis (NIH II) at the time of the trial. Reviewing the notes of those patients after almost 6 y we were unable to confirm this with the up-to-date standards. However we were able to diagnose chronic prostatitis without specifying the class (uCP). A group of 30 healthy individuals (group 'HI') visiting the well-man clinic at our outpatients department without signs and symptoms of a urogenital inflammation, a subjective symptom score of 0 and normal sperm analysis and four-glass tests served as control group.
Diagnostic procedures
Before treatment and 6 weeks, 3 months, 6 months and 1 y after treatment standard diagnostic procedures were performed on all men. This included the four-glass test. 7 -9 The first urine (VB1), the midstream urine (VB2), the EPS, if obtainable, and the post-massage urine (VB3) were investigated for the presence of leucocytes and bacteria. In the absence of leucocytes and bacteria in VB1 a significant increase of either of them in the EPS or VB3 allows localization of inflammation and infection, respectively, in the prostate.
A standard sperm analysis was performed, including a leucocyte count. 10 The sperm leucocyte count is regarded as an indicator of acute inflammatory activity in the male adnexe. 12 -14 The remaining sperm were centrifuged and the seminal fluid saved.
A subjective symptom score was obtained through a series of questions regarding perineal, suprapubic, penile, urethral and testicular pain, painful ejaculation, erectile dysfunction and haematospermia. In seven questions the maximum score was 21 for the worst symptoms. This was not a validated symptom score but included similar criteria as the NIH-CPSI. 6 Significant improvement was regarded as reduction of this score by 50%.
Immunobiochemistry
Nephelometry is widely used in clinical laboratories to measure immunoglobulins because it is relatively easily automated. We used a Behring Nephelometer 100 TM (Behringwerke AG, Marburg) to measure the immunoparameters in seminal fluid.
Antibody and the antigen are mixed in concentrations such that only small aggregates are formed that do not settle quickly to the bottom. The amount of light scatter is measured and compared to the amount of scatter from known mixtures. Initial technical problems due to the high viscosity of seminal fluid were overcome by dilution and warming the fluid to 37 C. For the measurements of IgG and IgA the CSF programme and a dilution of 1:5 was chosen. The reagents used were N-Antiserum against Human-IgG (w-chain) 1 and Human-IgA (a-chain) 1 (all Behringwerke AG, Marburg, Germany).
Statistics
To define the range of values in the group of healthy individuals (HI), the group of all prostatitis patients (CP) and the group of chronic abacterial prostatitis patients (CAP), the mean value, the standard deviation and the 95% confidence interval were established. For comparison of two independent sample collectives Student's t-test was used. In all cases a level of significance was accepted as P < 0.05. In the case of detection of a significance the lower limit of the 95% confidence interval of the prostatitis collective was used as the threshold to the pathological range of values. For this only the results of the screening visit were included.
To investigate the value of an immunoparameter for monitoring a healing process values taken at the screening visit and the last visit, either at six months or one year, were compared. It was noted whether the values decreased to normal, remained unchanged or were increased. Their occurrence in the groups of patients with no improvement of the disease according to their symptom score and patients with definite improvement over the observed period enabled us to define specificity and sensitivity.
We also investigated the behaviour of the immunoparameter in an exacerbation of chronic prostatitis. We defined an exacerbation as an increase of the symptom score by 1.5 times at any follow-up visit compared with the previous visit. We then compared the values of IgG and IgA with the sperm leucocyte count obtained at the same time. They were divided into three groups according to their respective leucocyte count (L0, 0 Mio/ml; L1, 0 -0.5 Mio/ml; L2, > 0.5 Mio/ml) as a measure for an acute inflammatory process. The collectives were compared with the Student's t-test.
Results
Immunoglobulin G
The mean value of IgG in the group of 30 healthy individuals (HI) was 0. 104( AE 0.014) g/l and the upper limit of the 95% confidence interval (95% CI) was 0.133 g/l. Thirtyone chronic prostatitis patients (CP) presented a mean value of 0.325( AE 0.05) g/l and a 95% CI of 0.218 -0.43 g/ l. Out of this group the CAP patients, 16 had a mean value of 0.341( AE 0.08) g/l and a 95% CI of 0.1577 -0.525 g/l. In the unclassified CP group 15 patients delivered a mean value of 0.307( AE 0.05) g/l and a 95% CI of 0.18 -0.435 g/l.
The comparison of the groups HI and CP (P ¼ 0.0002), HI and CAP (P ¼ 0.0007) and HI and uCP (P ¼ 0.0001) showed highly significant differences. Comparison of CAP and uCP (P ¼ 0.753) showed no significant differences. Therefore the lower limit of the 95% CI of the values of the CP group 0.218 g/l was regarded as the lower limit of the pathological range.
Out of the CP group, 14 patients showed no improvement of the disease during the follow-up period, of which four had decreased IgG values. Out of the 17 with improved disease 13 had decreased values of IgG. Therefore the sensitivity and specificity for this test to identify a healing process is 0.76 and 0.71, respectively.
Investigating the behaviour during an exacerbation it was found that group L0 (42 values) with a mean value of IgG of 0.209(AE0.23) g/l, group L1 (24) with a mean value of 0.219(AE0.13) g/l and group L2 (42) with a mean value of 0.276(AE0.2) g/l did not significantly differ (L0 -L1, P ¼ 0.8302; L0 -L2, P ¼ 0.1681; L1 -L2, P ¼ 0.1734).
Immunoglobulin A
The mean value of IgA in the group of 30 healthy individuals (HI) was 0.042(AE0.004) g/l and the upper limit of the 95% CI was 0.052 g/l.
Thirty-one chronic prostatitis patients (CP) presented a mean value of 0.182(AE0.02) g/l and a 95% CI of 0.122 -0.243 g/l. Out of this group the CAP patients (16) The comparison of the groups HI and CP (P ¼ 0.0001), HI and CAP (P ¼ 0.0001) and HI and uCP (P ¼ 0.0001) showed highly significant differences. Comparison of CAP and uCP (P ¼ 0.8568) showed no significant difference.
Therefore the lower limit of the 95% CI of the values of the CP group 0.122 g/l was regarded as the lower limit of the pathological range.
Out of the CP group, 14 patients showed no improvement of the disease during the follow-up period, of which five had decreased IgA values. Out of the 17 with improved disease, seven had decreased values of IgA. Therefore the sensitivity and specificity for this test to identify a healing process is 0.41 and 0.64, respectively.
Investigating the behaviour during an exacerbation it was found that group L0 (40 values) had a mean value of IgA of 0.109(AE0.13) g/l, group L1 (24) a mean value of 0.135(AE0.1) g/l and group L2 (43) a mean value of 0.194 (AE0.16) g/l. Comparison of L0 -L1 (P ¼ 0.365) and L1 -L2 (P ¼ 0.074) showed no significant difference whereas comparison of L0 -L2 (P ¼ 0.0108) did show a significant difference.
Discussion
The mean values in healthy individuals for IgG of 0.104(AE0.01) g/l and IgA of 0.042(AE0.004) g/l in seminal fluid established in this trial by nephelometry are about the same as those values defined by RIA found in literature 4, 15, 16 (see Table 1 ). Minimal differences are acceptable and are according to findings of Bauer et al 13, 18 because of different laboratory techniques and sizes of cohorts.
The comparison of the groups shows that there is a highly significant increase in levels of IgG and IgA from healthy individuals to CP and CAP patients, which agrees with the findings in previous work. However, the values of the uCP group did not show any significant difference from the CAP group values. Since literature reports higher levels of IgG and A in patients with CBP, a further study should be performed investigating measurements for this group with current standards.
IgG was found to be very reliable for monitoring the healing process over a long-term period (see Figure 1 ). It has a sensitivity of 0.76 and a specificity of 0.71 compared with 0.41 and 0.64, respectively, for IgA.
On the other hand relating the values of the immunoglobulins to the sperm leucocyte count showed a significantly higher mean value in the group with > 0.5 MioLc/ml compared with the group without leucocytes, and that IgA is reliable enough to monitor exacerbations (see Figure 2) .
We explain these observations with the findings of Shortliffe et al 4 and Bauer et al 11 that the immunoglobulins in fluids of the adnexe are increased due to loco-regional synthesis during chronic prostatitis. This synthesis of IgA only normalizes over a period of 6 -12 months after the resolution of the disease. However, according to Sziegoleit et al 17 IgA is also secreted by epithelial surfaces during the exudative phase of acute inflammatory processes, which nicely explains our findings. Our findings have to be interpreted with the knowledge that the investigated cohorts are small, and larger numbers are required to establish normal and pathological ranges. Both parameters were measured in seminal fluid and we cannot make a specific statement about processes in the prostate alone. They therefore have to be used in the framework of the standard investigations.
However the results and the easy and inexpensive laboratory technique should encourage the use of this method as an objective measure to confirm the findings of the subjective NIH-CPSI in trials of treatment for chronic prostatitis once investigated in a larger scale.
